SEC Form 4 · accession 0001209191-17-024757
Mellanox Technologies, Ltd. · MLNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eyal Waldman
Officer — President and CEO · Director
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Mar 31, 2017 | M | 10,000 | $8.23 | A | 458,968 | D | |
| Ordinary SharesF3,F2 | Mar 31, 2017 | S | 10,000 | $51.19 | D | 448,968 | D | |
| Ordinary SharesF2,F4 | holding | — | — | — | 1,426,041 | I | By Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F5 | $8.23 | Mar 31, 2017 | M | 10,000 | D | — | Dec 25, 2018 | Ordinary Shares | 10,000 | 0 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Includes 157,500 unvested Restricted Share Units (RSU's). Upon vesting thereof, the Reporting Person is entitled to receive one (1) Ordinary Share for each one (1) RSU.
- F3This transaction was executed in multiple trades in prices ranging from $50.40 to $51.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- F4Shares held by Waldo Holdings 2, a general partnership formed pursuant to the laws of Israel of which Mr. Waldman is a general partner. Mr. Waldman has sole voting and dispositive power over all of the shares reported on this Form 4.
- F5The Shares subject to this option are fully vested and exercisable.